Prescription Medications - Afatinib Produces Positive Results in Lung Cancer Patients

Prescription Medications Prescription Medications News - Exciting data on the effects of Afatinib in non-small cell lung cancer (NSCLC) patients will be presented this week at the Chicago Multidisciplinary Symposium in Thoracic Oncology.  The new data released from a LUX-Lung 1 trial shows that Afatinib provides a four-fold gain in progression-free survival for patients taking the drug.

Read more

Fri, 12/10/2010 - 08:05